Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition)
Jian Li(Beijing Normal University), Feng Lin(University of Nebraska Medical Center), Baoqing Jia(Chinese PLA General Hospital), Xu Zhu(Children's Hospital of Chongqing Medical University), Weijia Fang(Zhejiang Cancer Hospital), Yanhong Deng(Sun Yat-sen University), Xuedong Fang(Union Hospital), Kewei Jiang(Peking University), Fan Yang(Peking University People's Hospital), Chunmei Bai(Shanxi Medical University), Feng-yi Feng(Peking University), Yongheng Li(Fudan University Shanghai Cancer Center), Yi Ba(Tianjin Medical University Cancer Institute and Hospital), Shaolei Li(Peking University), Maode Lai(Chinese Academy of Medical Sciences & Peking Union Medical College), Ying Yuan(Zhejiang Cancer Hospital), Lin Chen(Xuzhou Medical College), Qihan Fu(First Affiliated Hospital Zhejiang University), Wei Bai(Chinese Academy of Medical Sciences & Peking Union Medical College), Leping Li(Shandong University), Shu Zheng(Zhejiang University), Zhenghang Wang(Peking University), Feng Bi(Tianjin University of Traditional Chinese Medicine), Ye‐Xiong Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Dechuan Li(Zhejiang Cancer Hospital), Yulong He(Sun Yat-sen University), Kefeng Ding(Second Affiliated Hospital of Zhejiang University), Chuangang Fu(Shanghai East Hospital), Ming Li(Central South University), Jianping Wang(Sun Yat-sen University), Jin Li(Shanghai East Hospital), Gong Chen(Guangdong Pharmaceutical University), Gu Yanhong, Li Bai(Army Medical University), Sanjun Cai(Shanghai Medical College of Fudan University), Jie He(First Affiliated Hospital of Jinan University), Xiaobo Liang(Affiliated Hospital of Southwest Medical University), Yi Wang(Peking University), Zhiyong Liang(Chinese Academy of Medical Sciences & Peking Union Medical College), Pan Chi(Fujian Medical University), Zhongwu Li(Peking University), Qingxia Fan(First Affiliated Hospital of Zhengzhou University), Guanghai Dai(Chinese PLA General Hospital), Enxiao Li(First Affiliated Hospital of Xi'an Jiaotong University), Ping Lan(Sun Yat-sen University), Kaican Cai(Nanfang Hospital), Pengju Chen(Peking University Cancer Hospital), Ke‐Neng Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Desen Wan(Sun Yat-sen University), Muyan Cai(Sun Yat-sen University)
Cited by 124
Related Papers
Cancer incidence and mortality in China, 2022
|Journal of the National Cancer Center|2024|2k
Cancer incidence and mortality in China, 2016
|Journal of the National Cancer Center|2022|1.6k
Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA
|Cell Research|2011|1.2k
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2023|1k